Concept information
Preferred term
Ranibizumab
Type
-
Topical Descriptor
Broader concept
Entry terms
- RhuFab V2
- V2, RhuFab
Scope note
- A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.
History note
- 2016 (2005)
In other languages
-
Finnish
-
Swedish
-
Lucentis
URI
http://www.yso.fi/onto/mesh/D000069579
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}